37 related articles for article (PubMed ID: 14997042)
1. Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma.
Faulkner S; Griffin N; Rowe CW; Jobling P; Lombard JM; Oliveira SM; Walker MM; Hondermarck H
FASEB Bioadv; 2020 Jul; 2(7):398-408. PubMed ID: 32676580
[TBL] [Abstract][Full Text] [Related]
2. Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulation.
Mayayo-Peralta I; Debets DO; Prekovic S; Schuurman K; Beerthuijzen S; Almekinders M; Sanders J; Moelans CB; Saleiro S; Wesseling J; van Diest PJ; Henrique R; Jerónimo C; Altelaar M; Zwart W
Mol Oncol; 2024 Jan; 18(1):156-169. PubMed ID: 37854018
[TBL] [Abstract][Full Text] [Related]
3. Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway.
Tani T; Oikawa M; Misaka T; Ishida T; Takeishi Y
JACC CardioOncol; 2024 Feb; 6(1):55-66. PubMed ID: 38510296
[TBL] [Abstract][Full Text] [Related]
4. Nerve Growth Factor/Tyrosine Kinase A Receptor Pathway Enhances Analgesia in an Experimental Mouse Model of Bone Cancer Pain by Increasing Membrane Levels of δ-Opioid Receptors.
Kan BF; Liu XY; Han MM; Yang CW; Zhu X; Jin Y; Wang D; Huang X; Wu WJ; Fu T; Kang F; Zhang Z; Li J
Anesthesiology; 2024 Apr; 140(4):765-785. PubMed ID: 38118180
[TBL] [Abstract][Full Text] [Related]
5. Cross-Disease Communication in Cardiovascular Disease and Cancer.
Von Itter R; Moore KJ
JACC CardioOncol; 2024 Feb; 6(1):67-70. PubMed ID: 38510295
[TBL] [Abstract][Full Text] [Related]
6. [A case report of acute fever and multiple plasma membrane effusions].
Liu HT; Shen M; Fan HW; Cao W
Zhonghua Nei Ke Za Zhi; 2024 Jan; 63(1):94-96. PubMed ID: 38186124
[TBL] [Abstract][Full Text] [Related]
7. NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.
Bradshaw RA; Pundavela J; Biarc J; Chalkley RJ; Burlingame AL; Hondermarck H
Adv Biol Regul; 2015 May; 58():16-27. PubMed ID: 25491371
[TBL] [Abstract][Full Text] [Related]
8. New determinates of disease progression and outcome in metastatic ovarian carcinoma.
Davidson B; Reich R; Trope CG; Wang TL; Shih IeM
Histol Histopathol; 2010 Dec; 25(12):1591-609. PubMed ID: 20886439
[TBL] [Abstract][Full Text] [Related]
9. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
[TBL] [Abstract][Full Text] [Related]
11. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma.
Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C
Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380
[TBL] [Abstract][Full Text] [Related]
12. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
14. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM
Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
